查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529757

混凝剂市场规模、份额、趋势分析报告：按产品、按应用、按管理管道、按地区、细分市场预测，2024-2030

Coagulants Market Size, Share & Trends Analysis Report By Product (Systemic, Topical, Hemostatics), By Application (Surgeries, Trauma, Hemophilia, Bleeding), By Route Of Administration, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

混凝剂市场规模及趋势

预计2023年全球混凝剂市场规模将达104.7亿美元，预计2024年至2030年复合年增长率为7.2%。医疗市场的主要驱动因素是出血性疾病和需要凝血因子进行治疗的慢性疾病的日益流行。血友病、血管性血友病、血栓症等疾病需要使用凝血因子来有效管理和控制。这些疾病的全球发病率不断上升正在推动对该市场的需求。

此外，技术进步和新型凝血疗法的开发正在推动创新并扩大这一领域。製造商正在投资研发以推出更有效、更安全的产品，例如重组凝血因子产品和延长半衰期的产品。这些进展旨在改善出血性疾病患者的治疗效果、减轻治疗负担并提高其整体生活品质。据美国疾病管制与预防美国称，截至 2024 年 5 月，美国估计约有 33,000 名男性患有血友病。

此外，医疗技术和研究的进步促进了新型凝血製剂的开发，其功效和安全性得到提升。重组凝血因子产品和延长半衰期产品等创新配方为患者提供了更方便的治疗选择并带来更好的结果。这些技术进步透过扩大可用治疗方法的范围和提高患者对治疗方法的依从性来推动成长。 2024年4月，Avenacy在美国上市了FDA核准的醋酸去氨加压素注射液，作为DDAVP注射液的非专利药替代品。此药用于治疗中枢性糖尿病、 A型血友病、I型冯维勒布兰氏症。

此外，旨在改善医疗基础设施和促进预防性医疗保健的有利政府措施和政策正在推动该行业的发展。世界各国政府都致力于加强获得优质卫生服务的机会，包括用于早期发现和管理凝血因子缺乏和高凝血状态等疾病的诊断检测设施。针对止血和血栓症形成研发活动的诱因也鼓励产业参与者投资于最尖端科技的开发。例如，与疾病管制与预防中心合作的国家血友病计画等倡议支持推进止血相关治疗的研究工作。

监管要求在推动医疗产业发挥重要作用。随着对病患安全和医疗品质的日益重视，包括食品药物管理局(FDA) 和欧洲药品管理局 (EMA) 在内的多个监管机构正在针对医疗机构实施严格的准则。这些法规确保了产品的安全性、有效性和质量，从而推动了对这些产品的需求。例如，FDA 制定了现行的良好生产规范 (CGMP) 法规，以确保产品在受控条件下生产，以维持特性、强度、品质和纯度。遵守这些法规要求製造商投资先进技术和设备，这推动了需求。

全球混凝剂市场报告细分

该报告预测了2018年至2030年全球、区域和国家层面的收益成长，并对每个子区隔的最新行业趋势进行了分析。在这项研究中，Grand View Research, Inc. 根据产品、应用、给药途径和地区对全球凝血剂市场报告进行了细分。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章混凝剂市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 混凝剂市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • 管道分析

第四章混凝剂市场：产品、估计与趋势分析

  • 全球混凝剂市场：产品仪表板
  • 全球混凝剂市场：产品波动分析
  • 按产品分類的收益
  • 局部凝固剂
  • 系统性混凝剂
  • 止血剂

第五章混凝剂市场：应用、估算与趋势分析

  • 全球混凝剂市场：应用仪表板
  • 全球混凝剂市场：应用变化分析
  • 按使用情况分類的收益
  • 外科手术
  • 外伤案例
  • 血友病
  • 出血性疾病
  • 其他的

第六章 混凝剂市场：管理通路、预测及趋势分析

  • 全球混凝剂市场：剂量通道仪表板
  • 全球混凝剂市场：管理通路变化分析
  • 按管理管道分類的收益
  • 局部给药
  • 肠外给药
  • 口服给药

第七章 混凝剂市场：按产品、应用和施用途径的区域估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第八章 竞争格局

  • 公司/竞争对手分类
  • 供应商情况
    • 2023年主要企业市场占有率分析
    • Johnson &Johnson.
    • Baxter International Inc.
    • Pfizer Inc.
    • Bristol-Myers Squibb Company
    • Sanofi SA
    • Bayer AG
    • Novo Nordisk A/S.
    • CSL Behring
    • Octapharma AG
    • Grifols SA
    • Amgen Inc.
    • Takeda Pharmaceutical Company Limited
Product Code: GVR-4-68040-347-9

Coagulants Market Size & Trends

The global coagulants market size was estimated at USD 10.47 billion in 2023 and is projected to grow at a CAGR of 7.2% from 2024 to 2030. The market in healthcare is primarily driven by the increasing prevalence of bleeding disorders and chronic diseases that require blood clotting factors for treatment. Conditions like hemophilia, von Willebrand disease, and thrombophilia necessitate the use of coagulants to manage and control them effectively. The rising incidence of these disorders globally is propelling the demand for this market.

Moreover, technological advancements and the development of novel coagulation therapies are driving innovation and expanding the sector. Manufacturers are investing in research and development to introduce more efficacious and safer products, including recombinant clotting factors and extended half-life products. These advancements aim to enhance patient outcomes, reduce treatment burden, and improve overall quality of life for individuals with bleeding disorders. According to Centers for Disease Control and Prevention, it's estimated that around 33,000 males in the U.S. are living with hemophilia as of May 2024.

Moreover, advancements in medical technology and research have led to development of novel coagulant products with improved efficacy and safety profiles. Innovations like recombinant clotting factors and extended half-life products offer patients more convenient treatment options and better outcomes. These technological advancements drive growth by expanding the range of available therapies and enhancing patient adherence to treatment regimens. In April 2024, Avenacy launched its FDA-approved Desmopressin Acetate Injection in the U.S., serving as a generic alternative to DDAVP Injection. This medication is aimed at treating central diabetes insipidus, hemophilia A, and Type I von Willebrand's disease.

Furthermore, favorable government initiatives and policies aimed at improving healthcare infrastructure and promoting preventive care are boosting the industry. Governments worldwide are focusing on enhancing access to quality healthcare services, including diagnostic testing facilities for early detection and management of disorders such as clotting factor deficiencies and hypercoagulable states. Incentives for research and development activities focused on hemostasis and thrombosis have also encouraged industry players to invest in developing cutting-edge technologies. For instance, initiatives like the National Hemophilia Program are done in collaboration with Centers for Disease Control and Prevention in the U.S. support research efforts to advance hemostasis-related treatments.

Regulatory requirements play a significant role in driving the healthcare industry. With the increasing emphasis on patient safety and quality care, several regulatory bodies including Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have implemented strict guidelines in healthcare settings. These regulations ensure that the products are safe, effective, and of high quality, thereby driving demand for these products. For instance, the FDA has established the Current Good Manufacturing Practice (CGMP) regulations to ensure that they are product under controlled conditions to maintain their identity, strength, quality, and purity. Compliance with these regulations requires manufacturers to invest in advanced technologies and equipment, which in turn drives the demand.

Global Coagulants Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global coagulants market report based on product, application, route of administration, and region.

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Topical Coagulants
  • Absorbable Gelatin
  • Oxidized Cellulose
  • Microfibrillar Collagen
  • Other topical coagulants
  • Systemic Coagulants
  • Vitamin K
  • Protamine
  • Desmopressin
  • Fibrinogen
  • Other systemic coagulants
  • Hemostatics
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Surgeries
  • Trauma Cases
  • Hemophilia
  • Bleeding Disorders
  • Other Applications
  • Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
  • Topical Administration
  • Parenteral Administration
  • Oral Administration
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

Germany

UK

France

Italy

Spain

Denmark

Sweden

Norway

  • Asia Pacific

China

Japan

India

South Korea

Australia

Thailand

  • Latin America

Brazil

Argentina

  • Middle East and Africa (MEA)

South Africa

Saudi Arabia

Kuwait

UAE

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. Route of Administration
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product and Application outlook
    • 2.2.2. Route of Administration outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Coagulants Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Technological advancements in diagnostic tools and treatment options
      • 3.2.1.2. Increasing prevalence of coagulants disorders and chronic diseases
      • 3.2.1.3. Expanding applications of coagulants testing in various medical fields including hematology, oncology, and critical care
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Regulatory Challenges
  • 3.3. Coagulants Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pipeline Analysis

Chapter 4. Coagulants Market: Product Estimates & Trend Analysis

  • 4.1. Global Coagulants Market: Product Dashboard
  • 4.2. Global Coagulants Market: Product Movement Analysis
  • 4.3. Global Coagulants Market by Product, Revenue
  • 4.4. Topical Coagulants
    • 4.4.1. Topical coagulants market estimates and forecasts 2018 to 2030, (USD Million)
    • 4.4.2. Absorbable Gelatin
      • 4.4.2.1. Absorbable gelatin market estimates and forecasts 2018 to 2030, (USD Million)
    • 4.4.3. Oxidized Cellulose
      • 4.4.3.1. Oxidized cellulose market estimates and forecasts 2018 to 2030, (USD Million)
    • 4.4.4. Microfibrillar Collagen
      • 4.4.4.1. Microfibrillar collagen market estimates and forecasts 2018 to 2030, (USD Million)
    • 4.4.5. Other topical coagulants
      • 4.4.5.1. Other topical coagulants market estimates and forecasts 2018 to 2030, (USD Million)
  • 4.5. Systemic Coagulants
    • 4.5.1. Systemic coagulants market estimates and forecasts 2018 to 2030, (USD Million)
    • 4.5.2. Vitamin K
      • 4.5.2.1. Vitamin K market estimates and forecasts 2018 to 2030, (USD Million)
    • 4.5.3. Protamine
      • 4.5.3.1. Protamine market estimates and forecasts 2018 to 2030, (USD Million)
    • 4.5.4. Desmopressin
      • 4.5.4.1. Desmopressin market estimates and forecasts 2018 to 2030, (USD Million)
    • 4.5.5. Fibrinogen
      • 4.5.5.1. Fibrinogen market estimates and forecasts 2018 to 2030, (USD Million)
    • 4.5.6. Other systemic coagulants
      • 4.5.6.1. Other systemic coagulants market estimates and forecasts 2018 to 2030, (USD Million)
  • 4.6. Hemostatics
    • 4.6.1. Hemostatics coagulants market estimates and forecasts 2018 to 2030, (USD Million)

Chapter 5. Coagulants Market: Application Estimates & Trend Analysis

  • 5.1. Global Coagulants Market: Application Dashboard
  • 5.2. Global Coagulants Market: Application Movement Analysis
  • 5.3. Global Coagulants Market Estimates and Forecasts, By Application, Revenue (USD Million)
  • 5.4. Surgeries
    • 5.4.1. Surgeries market estimates and forecasts 2018 to 2030, (USD Million)
  • 5.5. Trauma Cases
    • 5.5.1. Trauma cases market estimates and forecasts 2018 to 2030, (USD Million)
  • 5.6. Hemophilia
    • 5.6.1. Hemophilia market estimates and forecasts 2018 to 2030, (USD Million)
  • 5.7. Bleeding Disorders
    • 5.7.1. Bleeding disorders market estimates and forecasts 2018 to 2030, (USD Million)
  • 5.8. Other Applications
    • 5.8.1. Other applications market estimates and forecasts 2018 to 2030, (USD Million)

Chapter 6. Coagulants Market: Route of Administration Estimates & Trend Analysis

  • 6.1. Global Coagulants Market: Route of Administration Dashboard
  • 6.2. Global Coagulants Market: Route of Administration Movement Analysis
  • 6.3. Global Coagulants Market Estimates and Forecasts, by Route of Administration, Revenue (USD Million)
  • 6.4. Topical Administration
    • 6.4.1. Topical administration market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.5. Parenteral Administration
    • 6.5.1. Parenteral administration market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.6. Oral Administration
    • 6.6.1. Oral Administration market estimates and forecasts 2018 to 2030, (USD Million)

Chapter 7. Coagulants Market: Regional Estimates & Trend Analysis by Product, Application, and Route of Administration

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030, (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030, (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030, (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030, (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030, (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030, (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030, (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030, (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030, (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030, (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030, (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030, (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030, (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030, (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030, (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030, (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030, (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030, (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030, (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030, (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030, (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030, (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030, (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Vendor Landscape
    • 8.2.1. List of key distributors and channel partners
    • 8.2.2. Key customers
    • 8.2.3. Key company market share analysis, 2023
    • 8.2.4. Johnson & Johnson.
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Baxter International Inc.
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Pfizer Inc.
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Bristol-Myers Squibb Company
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Sanofi S.A.
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Bayer AG
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Novo Nordisk A/S.
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives
    • 8.2.11. CSL Behring
      • 8.2.11.1. Company overview
      • 8.2.11.2. Financial performance
      • 8.2.11.3. Product benchmarking
      • 8.2.11.4. Strategic initiatives
    • 8.2.12. Octapharma AG
      • 8.2.12.1. Company overview
      • 8.2.12.2. Financial performance
      • 8.2.12.3. Product benchmarking
      • 8.2.12.4. Strategic initiatives
    • 8.2.13. Grifols S.A.
      • 8.2.13.1. Company overview
      • 8.2.13.2. Financial performance
      • 8.2.13.3. Product benchmarking
      • 8.2.13.4. Strategic initiatives
    • 8.2.14. Amgen Inc.
      • 8.2.14.1. Company overview
      • 8.2.14.2. Financial performance
      • 8.2.14.3. Product benchmarking
      • 8.2.14.4. Strategic initiatives
    • 8.2.15. Takeda Pharmaceutical Company Limited
      • 8.2.15.1. Company overview
      • 8.2.15.2. Financial performance
      • 8.2.15.3. Product benchmarking
      • 8.2.15.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America coagulants market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America coagulants market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America coagulants market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America coagulants market, by route of administration, 2018 - 2030 (USD Million)
  • Table 6 U.S. coagulants market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. coagulants market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. coagulants market, by route of administration, 2018 - 2030 (USD Million)
  • Table 9 Canada coagulants market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada coagulants market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada coagulants market, by route of administration, 2018 - 2030 (USD Million)
  • Table 12 Mexico coagulants market, by product, 2018 - 2030 (USD Million)
  • Table 13 Mexico coagulants market, by application, 2018 - 2030 (USD Million)
  • Table 14 Mexico coagulants market, by route of administration, 2018 - 2030 (USD Million)
  • Table 15 Europe coagulants market, by region, 2018 - 2030 (USD Million)
  • Table 16 Europe coagulants market, by product, 2018 - 2030 (USD Million)
  • Table 17 Europe coagulants market, by application, 2018 - 2030 (USD Million)
  • Table 18 Europe coagulants market, by route of administration, 2018 - 2030 (USD Million)
  • Table 19 Germany coagulants market, by product, 2018 - 2030 (USD Million)
  • Table 20 Germany coagulants market, by application, 2018 - 2030 (USD Million)
  • Table 21 Germany coagulants market, by route of administration, 2018 - 2030 (USD Million)
  • Table 22 Germany coagulants market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 23 UK coagulants market, by product, 2018 - 2030 (USD Million)
  • Table 24 UK coagulants market, by application, 2018 - 2030 (USD Million)
  • Table 25 UK coagulants market, by route of administration, 2018 - 2030 (USD Million)
  • Table 26 France coagulants market, by product, 2018 - 2030 (USD Million)
  • Table 27 France coagulants market, by application, 2018 - 2030 (USD Million)
  • Table 28 France coagulants market, by route of administration, 2018 - 2030 (USD Million)
  • Table 29 Italy coagulants market, by product, 2018 - 2030 (USD Million)
  • Table 30 Italy coagulants market, by application, 2018 - 2030 (USD Million)
  • Table 31 Italy coagulants market, by route of administration, 2018 - 2030 (USD Million)
  • Table 32 Spain coagulants market, by product, 2018 - 2030 (USD Million)
  • Table 33 Spain coagulants market, by application, 2018 - 2030 (USD Million)
  • Table 34 Spain coagulants market, by route of administration, 2018 - 2030 (USD Million)
  • Table 35 Denmark coagulants market, by product, 2018 - 2030 (USD Million)
  • Table 36 Denmark coagulants market, by application, 2018 - 2030 (USD Million)
  • Table 37 Denmark coagulants market, by route of administration, 2018 - 2030 (USD Million)
  • Table 38 Sweden coagulants market, by product, 2018 - 2030 (USD Million)
  • Table 39 Sweden coagulants market, by application, 2018 - 2030 (USD Million)
  • Table 40 Sweden coagulants market, by route of administration, 2018 - 2030 (USD Million)
  • Table 41 Norway coagulants market, by product, 2018 - 2030 (USD Million)
  • Table 42 Norway coagulants market, by application, 2018 - 2030 (USD Million)
  • Table 43 Norway coagulants market, by route of administration, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific coagulants market, by region, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific coagulants market, by product, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific coagulants market, by application, 2018 - 2030 (USD Million)
  • Table 47 Aisa Pacific coagulants market, by route of administration, 2018 - 2030 (USD Million)
  • Table 48 China coagulants market, by product, 2018 - 2030 (USD Million)
  • Table 49 China coagulants market, by application, 2018 - 2030 (USD Million)
  • Table 50 China coagulants market, by route of administration, 2018 - 2030 (USD Million)
  • Table 51 Japan coagulants market, by product, 2018 - 2030 (USD Million)
  • Table 52 Japan coagulants market, by application, 2018 - 2030 (USD Million)
  • Table 53 Japan coagulants market, by route of administration, 2018 - 2030 (USD Million)
  • Table 54 India coagulants market, by product, 2018 - 2030 (USD Million)
  • Table 55 India coagulants market, by application, 2018 - 2030 (USD Million)
  • Table 56 India coagulants market, by route of administration, 2018 - 2030 (USD Million)
  • Table 57 South Korea coagulants market, by product, 2018 - 2030 (USD Million)
  • Table 58 South Korea coagulants market, by application, 2018 - 2030 (USD Million)
  • Table 59 South Korea coagulants market, by route of administration, 2018 - 2030 (USD Million)
  • Table 60 Australia coagulants market, by product, 2018 - 2030 (USD Million)
  • Table 61 Australia coagulants market, by application, 2018 - 2030 (USD Million)
  • Table 62 Australia coagulants market, by route of administration, 2018 - 2030 (USD Million)
  • Table 63 Thailand coagulants market, by product, 2018 - 2030 (USD Million)
  • Table 64 Thailand coagulants market, by application, 2018 - 2030 (USD Million)
  • Table 65 Thailand coagulants market, by route of administration, 2018 - 2030 (USD Million)
  • Table 66 Latin America coagulants market, by region, 2018 - 2030 (USD Million)
  • Table 67 Latin America coagulants market, by product, 2018 - 2030 (USD Million)
  • Table 68 Latin America coagulants market, by application, 2018 - 2030 (USD Million)
  • Table 69 Latin America coagulants market, by route of administration, 2018 - 2030 (USD Million)
  • Table 70 Brazil coagulants market, by product, 2018 - 2030 (USD Million)
  • Table 71 Brazil coagulants market, by application, 2018 - 2030 (USD Million)
  • Table 72 Brazil coagulants market, by route of administration, 2018 - 2030 (USD Million)
  • Table 73 Argentina coagulants market, by product, 2018 - 2030 (USD Million)
  • Table 74 Argentina coagulants market, by application, 2018 - 2030 (USD Million)
  • Table 75 Argentina coagulants market, by route of administration, 2018 - 2030 (USD Million)
  • Table 76 MEA coagulants market, by region, 2018 - 2030 (USD Million)
  • Table 77 MEA coagulants market, by product, 2018 - 2030 (USD Million)
  • Table 78 MEA coagulants market, by application, 2018 - 2030 (USD Million)
  • Table 79 MEA coagulants market, by route of administration, 2018 - 2030 (USD Million)
  • Table 80 South Africa coagulants market, by product, 2018 - 2030 (USD Million)
  • Table 81 South Africa coagulants market, by application, 2018 - 2030 (USD Million)
  • Table 82 South Africa coagulants market, by route of administration, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia coagulants market, by product, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia coagulants market, by application, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia coagulants market, by route of administration, 2018 - 2030 (USD Million)
  • Table 86 UAE coagulants market, by product, 2018 - 2030 (USD Million)
  • Table 87 UAE coagulants market, by application, 2018 - 2030 (USD Million)
  • Table 88 UAE coagulants market, by route of administration, 2018 - 2030 (USD Million)
  • Table 89 Kuwait coagulants market, by product, 2018 - 2030 (USD Million)
  • Table 90 Kuwait coagulants market, by application, 2018 - 2030 (USD Million)
  • Table 91 Kuwait coagulants market, by route of administration, 2018 - 2030 (USD Million)

List of Figures

  • Fig.1 Market research process
  • Fig.2 Data triangulation techniques
  • Fig.3 Primary research pattern
  • Fig.4 Primary interviews in North America
  • Fig.5 Primary interviews in Europe
  • Fig.6 Primary interviews in APAC
  • Fig.7 Primary interviews in Latin America
  • Fig.8 Primary interviews in MEA
  • Fig.9 Market research approaches
  • Fig.10 Value-chain-based sizing & forecasting
  • Fig.11 QFD modeling for market share assessment
  • Fig.12 Market formulation & validation
  • Fig.13 Coagulants market: market outlook
  • Fig.14 Coagulants competitive insights
  • Fig.15 Parent market outlook
  • Fig.16 Related/ancillary market outlook
  • Fig.17 Coagulants market driver impact
  • Fig.18 Coagulants market restraint impact
  • Fig.19 Coagulants market: Product movement analysis
  • Fig.20 Coagulants market: Product outlook and key takeaways
  • Fig.21 Topical coagulants market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig.22 Absorbable gelatin market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig.23 Oxidized cellulose market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig.24 Microfibrillar collagen market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig.25 Other topical coagulants market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig.26 Systemic coagulants market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig.27 Vitamin K market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig.28 Protamine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig.29 Desmopressin market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig.30 Fibrinogen market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig.31 Other systemic coagulants market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig.32 Hemostatics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig.33 Coagulants market: Application product movement analysis
  • Fig.34 Coagulants market: Application product outlook and key takeaways
  • Fig.35 Surgeries market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig.36 Trauma Cases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig.37 Hemophilia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig.38 Bleeding Disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig.39 Other Applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig.40 Coagulants market: Route of administration movement analysis
  • Fig.41 Coagulants market: Route of administration outlook and key takeaways
  • Fig.42 Topical Administration market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig.43 Parenteral Administration market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig.44 Oral Administration market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig.45 Global Coagulants market: Regional outlook and key takeaways
  • Fig.46 Global Coagulants market share and leading players
  • Fig.47 North America, by country
  • Fig.48 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.49 U.S. key country dynamics
  • Fig.50 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.51 Canada key country dynamics
  • Fig.52 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.53 Mexico key country dynamics
  • Fig.54 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.55 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.56 UK key country dynamics
  • Fig.57 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.58 Germany key country dynamics
  • Fig.59 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.60 France key country dynamics
  • Fig.61 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.62 Italy key country dynamics
  • Fig.63 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.64 Spain key country dynamics
  • Fig.65 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.66 Denmark key country dynamics
  • Fig.67 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.68 Sweden key country dynamics
  • Fig.69 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.70 Norway key country dynamics
  • Fig.71 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.72 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.73 China key country dynamics
  • Fig.74 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.75 Japan key country dynamics
  • Fig.76 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.77 India key country dynamics
  • Fig.78 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.79 Thailand key country dynamics
  • Fig.80 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.81 South Korea key country dynamics
  • Fig.82 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.83 Australia key country dynamics
  • Fig.84 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.85 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.86 Brazil key country dynamics
  • Fig.87 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.88 Argentina key country dynamics
  • Fig.89 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.90 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.91 South Africa key country dynamics
  • Fig.92 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.93 Saudi Arabia key country dynamics
  • Fig.94 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.95 UAE key country dynamics
  • Fig.96 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.97 Kuwait key country dynamics
  • Fig.98 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.99 Market share of key market players- coagulants market